5-AZACYTIDINE PERMITS GENE ACTIVATION IN A PREVIOUSLY NONINDUCIBLE CELL TYPE

被引：82
|
作者：
CHIU, CP
BLAU, HM
机构：
来源：
CELL | 1985年 / 40卷 / 02期
关键词：
D O I：
10.1016/0092-8674(85)90155-2
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：417 / 424
页数：8
相关论文
共 50 条
  • [21] TERIFLUNOMIDE RESTORES 5-AZACYTIDINE SENSITIVITY VIA ACTIVATION OF PYRIMIDINE SALVAGE IN 5-AZACYTIDINE-RESISTANT LEUKEMIA CELLS
    Imanishi, S.
    Takahashi, R.
    Katagiri, S.
    Umezu, T.
    Kobayashi, C.
    Ohyashiki, K.
    Ohyashiki, J.
    LEUKEMIA RESEARCH, 2017, 55 : S65 - S65
  • [22] 5-Azacytidine suppresses RNA polymerase II recruitment to the SLPI gene
    Wada, H
    Kagoshima, M
    Ito, K
    Barnes, PJ
    Adcock, IM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (01) : 93 - 99
  • [23] EFFECT OF 5-AZACYTIDINE ON GENE-EXPRESSION IN MARROW STROMAL CELLS
    ANDREWS, DF
    NEMUNAITIS, J
    TOMPKINS, C
    SINGER, JW
    MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (06) : 2748 - 2751
  • [24] Effect of 5-azacytidine on gene expression and development of preimplantation mouse embryos
    Kim, JW
    Lee, YH
    Yoon, HS
    Kim, MK
    BIOLOGY OF REPRODUCTION, 1997, 56 : 423 - 423
  • [25] ACTIVATION OF A CHICKEN EMBRYONIC GLOBIN GENE IN ADULT ERYTHROID-CELLS BY 5-AZACYTIDINE AND SODIUM-BUTYRATE
    GINDER, GD
    WHITTERS, MJ
    POHLMAN, JK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (13): : 3954 - 3958
  • [26] ACTIVATION OF THE MAJOR LATE PROMOTER IN ADENOVIRUS TRANSFORMED-CELLS BY 5-AZACYTIDINE
    ROBERT, N
    TOTH, M
    TELLIER, R
    HORVATH, J
    DERY, CV
    WEBER, JM
    VIROLOGY, 1988, 165 (01) : 296 - 298
  • [27] Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy
    Xu, Ning
    Tse, Benjamin
    Yang, Lu
    Tang, Tiffany Cy
    Haber, Michelle
    Micklethwaite, Kenneth
    Dolnikov, Alla
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 123 - 140
  • [28] 5-AZACYTIDINE INDUCED MYOGENESIS IN A DIFFERENTIATION DEFECTIVE CELL-LINE
    WALKER, C
    SHAY, JW
    DIFFERENTIATION, 1984, 25 (03) : 259 - 263
  • [29] Pharmacodynamic study of 5-azacytidine in the P39 cell line
    Khan, R
    Aggerholm, A
    Hokland, P
    Hassan, M
    Hellström-Lindberg, E
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (01) : 35 - 43
  • [30] Successful treatment of donor cell derived myelodysplastic syndrome with 5-azacytidine
    Jennane, Selim
    El Haddad, Mariyam
    Mahtat, El Mehdi
    Doghmi, Kamal
    Mikdame, Mohammed
    ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (06) : 713 - 714
12345